ストックスクリーナーアプリを入手
0.131
5.21%
-0.0072
アフターアワーズ：
.13
-0.001
-0.76%
前日終値:
$0.1382
開ける：
$0.1368
24時間の取引高:
5.52M
Relative Volume:
0.87
時価総額：
$128.37M
収益：
$25.19M
当期純損益:
$-34.53M
株価収益率:
-3.6389
EPS:
-0.036
ネットキャッシュフロー:
$-20.62M
1週間 パフォーマンス:
-10.82%
1か月 パフォーマンス:
+5.22%
6か月 パフォーマンス:
-9.41%
1年 パフォーマンス:
-18.38%
1日の値動き範囲:
$0.1301
$0.1379
1週間の範囲:
$0.1301
$0.1533
52週間の値動き範囲:
$0.117
$0.1952
Zomedica Corp Stock (ZOM) Company Profile
名前
Zomedica Corp
セクター
電話
734-369-2555
住所
100 Phoenix Drive, Suite 190, Ann Arbor, MI
ZOM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZOM
Zomedica Corp
|
0.131 | 128.37M | 25.19M | -34.53M | -20.62M | -0.036 |
|
ZTS
Zoetis Inc
|
163.32 | 73.68B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.10 | 41.15B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.95 | 41.06B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.94 | 23.73B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
140.90 | 14.27B | 2.24B | 385.90M | 440.10M | 3.73 |
Zomedica Corp Stock (ZOM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-01-06 | 開始されました | Dawson James | Buy |
Zomedica Corp (ZOM) 最新ニュース
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s What Happened - Defense World
Geode Capital Management LLC Buys 321,395 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) - Defense World
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s Why - Defense World
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2%What's Next? - MarketBeat
Zomedica enters license and supply agreement with Cresilon Inc. - DVM 360
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - AccessWire
Zomedica Secures Exclusive U.S. Rights to Revolutionary Vetigel Bleeding Control Technology - StockTitan
Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health - AOL
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - AccessWire
Zomedica Expands TRUFORMA Platform with Breakthrough 20-Minute Cardiac and Breeding Diagnostic Tests - StockTitan
Zomedica appoints Scott Jordan as EVP, finance & CFO - MSN
Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% – Here’s Why - Defense World
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - AccessWire
Zomedica Strengthens Leadership: Industry Veteran with 30+ Years Experience Named New CFO - StockTitan
Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8%Should You Sell? - MarketBeat
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - AccessWire
Zomedica CEO to Present at NobleCon20 Conference, Investor Meetings Scheduled - StockTitan
Zomedica secures new lease for headquarters expansion By Investing.com - Investing.com South Africa
Zomedica secures new lease for headquarters expansion - Investing.com
Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - AccessWire
Zomedica Launches 18-Minute Equine Insulin Test, Expands TRUFORMA Platform Capabilities | ZOM Stock News - StockTitan
Johnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) Stock - MarketBeat
Zomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble Financial - MarketBeat
Noble Capital Markets Initiates Equity Research Coverage on Zomedica - WICZ
Zomedica (ZOM) Launches Noble Capital Markets Coverage to Boost Market Visibility | ZOM Stock News - StockTitan
Zomedica initiated with an Outperform at Noble Capital - TipRanks
Zomedica Corp. (AMEX:ZOM) Q3 2024 Earnings Call Transcript - Insider Monkey
Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Earnings call: Zomedica reports record Q3 revenue, eyes future growth By Investing.com - Investing.com Australia
Zomedica stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa
Earnings call: Zomedica reports record Q3 revenue, eyes future growth - Investing.com
Zomedica’s Revenue Up 10% Amid Global Expansion - TipRanks
Zomedica stock plunges to 52-week low of $0.12 amid market challenges - Investing.com India
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - Herald Palladium
Zomedica CEO to Present at Sidoti Micro Cap Conference, Showcases Pet Health Innovation | ZOM Stock News - StockTitan
Zomedica Corp Posts Increased Revenue Amid Loss - TipRanks
Zomedica Announces Third Quarter 2024 Financial Results: Revenue - WICZ
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - AccessWire
Zomedica Q3 Revenue Jumps 10%, Diagnostics Surges 38% Despite Wider Losses | ZOM Stock News - StockTitan
Zomedica stock plunges to 52-week low at $0.12 amid market challenges - Investing.com India
ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - AccessWire
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - AccessWire
Zomedica stock plunges to 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa
Adversity is less terrifying than hope: Zomedica Corp (ZOM) - SETE News
Zomedica Corp (ZOM) 財務データ
収益
当期純利益
現金流量
EPS
1.04%
2.00%
大文字化:
|
ボリューム (24 時間):